Cargando…

Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3(+)CD4(+) T Cells

Two cytokines, fms-related tyrosine kinase 3 ligand (Flt3-L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are considered to be the essential regulators of dendritic cell (DC) development in vivo. However, the combined effect of Flt3-L and GM-CSF on human DCs has not been evaluated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwabuchi, Ryutaro, Ikeno, Shota, Kobayashi-Ishihara, Mie, Takeyama, Haruko, Ato, Manabu, Tsunetsugu-Yokota, Yasuko, Terahara, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985304/
https://www.ncbi.nlm.nih.gov/pubmed/29892279
http://dx.doi.org/10.3389/fimmu.2018.01042
Descripción
Sumario:Two cytokines, fms-related tyrosine kinase 3 ligand (Flt3-L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are considered to be the essential regulators of dendritic cell (DC) development in vivo. However, the combined effect of Flt3-L and GM-CSF on human DCs has not been evaluated in vivo. In this study, we, therefore, aimed at evaluating this using a humanized mouse model. Humanized non-obese diabetic/SCID/Jak3(null) (hNOJ) mice were constructed by transplanting hematopoietic stem cells from human umbilical cord blood into newborn NOJ mice, and in vivo transfection (IVT) was performed by hydrodynamic injection-mediated gene delivery using plasmids encoding human Flt3-L and GM-CSF. Following IVT, Flt3-L and GM-CSF were successfully induced in hNOJ mice. At 10 days post-IVT, we found, in the spleen, that treatment with both Flt3-L and GM-CSF enhanced the reconstitution of two myeloid DC subsets, CD14(−)CD1c(+) conventional DCs (cDCs) and CD14(−)CD141(+) cDCs, in addition to CD14(+) monocyte-like cells expressing CD1c and/or CD141. GM-CSF alone had less effect on the reconstitution of these myeloid cell populations. By contrast, none of the cytokine treatments enhanced CD123(+) plasmacytoid DC (pDC) reconstitution. Regardless of the reconstitution levels, three cell populations (CD1c(+) myeloid cells, CD141(+) myeloid cells, and pDCs) could be matured by treatment with cytokines, in terms of upregulation of CD40, CD80, CD86, and CD184/CXCR4 and downregulation of CD195/CCR5. In particular, GM-CSF contributed to upregulation of CD80 in all these cell populations. Interestingly, we further observed that Foxp3(+) cells within splenic CD4(+) T cells were significantly increased in the presence of GM-CSF. Foxp3(+) T cells could be subdivided into two subpopulations, CD45RA(−)Foxp3(hi) and CD45RA(−)Foxp3(lo) T cells. Whereas CD45RA(−)Foxp3(hi) T cells were increased only after treatment with GM-CSF alone, CD45RA(−)Foxp3(lo) T cells were increased only after treatment with both Flt3-L and GM-CSF. Treatment with Flt3-L alone had no effect on the number of Foxp3(+) T cells. The correlation analysis demonstrated that the development of these Foxp3(+) subpopulations was associated with the maturation status of DC(-like) cells. Taken together, this study provides a platform for studying the in vivo effect of Flt3-L and GM-CSF on human DCs and regulatory T cells.